Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Liquid Biopsy Fusion Gene Panel is 10 business days.

What are the prerequisites for the test Liquid Biopsy Fusion Gene Panel

  • Patients must have a confirmed diagnosis of cancer
  • Patients must have a physician's order for the test
  • Prior to testing, patients must have a blood sample collected by a healthcare provider
  • Patients must not have received any blood transfusions within the past 3 months

What are the measure values for the test Liquid Biopsy Fusion Gene Panel

  • Measure Name: Liquid Biopsy Fusion Gene Panel
  • Measure Type: Biomarker
  • Test Method: Next-Generation Sequencing (NGS)
  • Gene Panel: Includes fusion genes commonly found in various cancers
  • Sample Type: Blood or plasma
  • Turnaround Time: Typically 7-10 days
  • Accuracy: Sensitivity of 95-99% and specificity of 98-100%

What does this test Liquid Biopsy Fusion Gene Panel identify?

  1. EGFR (Epidermal Growth Factor Receptor) Mutations: Identifies mutations in the EGFR gene, which can be targeted by specific therapies.
  2. ALK (Anaplastic Lymphoma Kinase) Rearrangements: Detects rearrangements in the ALK gene, which are associated with certain types of cancer.
  3. ROS1 (ROS Proto-Oncogene 1) Rearrangements: Identifies rearrangements in the ROS1 gene, which can be targeted by specific treatments.
  4. BRAF (B-Raf Proto-Oncogene) Mutations: Detects mutations in the BRAF gene, which are important in the development of certain cancers.
  5. KRAS (Kirsten Rat Sarcoma Virus) Mutations: Identifies mutations in the KRAS gene, which can impact treatment options and prognosis.

Why is this test Liquid Biopsy Fusion Gene Panel taken?

Click to expand

The Liquid Biopsy Fusion Gene Panel test is taken to detect specific genetic mutations or alterations in cancer cells. This test helps in identifying fusion genes, which are abnormal genes formed when two separate genes fuse together. Fusion genes can play a crucial role in the development and progression of certain types of cancer.

By analyzing fusion genes through liquid biopsy, doctors can gain valuable insights into the underlying genetic changes driving the cancer, which can help in determining the most appropriate treatment options for the patient. This test can also be used to monitor the effectiveness of targeted therapies and track any changes in the fusion genes over time.

No FAQs available.

Customer Google Rating